F74. CLINICAL SYMPTOMS AND NOT OBJECTIVE COGNITIVE PERFORMANCE DRIVE SUBJECTIVE COGNITIVE COMPLAINTS IN PATIENTS WITH SCHIZOPHRENIA

BACKGROUND: The United States Food and Drug Administration (FDA) recommends that drugs that exert a pro-cognitive effect should be accompanied by measurable improvements in ‘real-world’ functioning. Patients with schizophrenia typically exhibit substantial impairments across a wide range of cognitiv...

Full description

Saved in:
Bibliographic Details
Published in:Schizophr Bull
Main Authors: Cotter, Jack, Granger, Kiri, Evenden, John, Barnett, Jennifer, Sand, Michael
Format: Artigo
Language:Inglês
Published: Oxford University Press 2018
Subjects:
Abstracts
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5888865/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby017.605
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items